May 14, 2007 - AutoGenomics Inc., a leader in developing automated molecular testing solutions, announced today that it has obtained clearance from the FDA to market its INFINITI Analyzer as stand alone instrumentation for multiplexed assays. In February, this year, the company reported that it had obtained clearance for its INFINITI System Assay for Factor II & Factor V as an in vitro diagnostic device that consisted of reagents and instrumentation.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now